The MRP MCAA supports independent, mid-career investigators to conduct impactful research in the field of melanoma. The MCAA presents an opportunity for mid-career investigators with prior experience in melanoma research and/or patient care to obtain funding to perform impactful research that will accelerate their career to become leaders in the melanoma research community. Preliminary data relevant to melanoma are required. Logical reasoning and a sound scientific rationale for the proposed research must be demonstrated.
Synergy with the FY21 MRP Melanoma Academy. To enhance networking and collaboration options for both the MCAA Principal Investigator (PI) and Melanoma Academy Scholars, MCAA PIs will be encouraged to participate in Melanoma Academy activities (networking events, seminars hosted by the MRP Melanoma Academy Leadership, etc.) as appropriate. MCAA PIs will be required to attend one meeting hosted by the FY21 MRP Melanoma Academy Leadership during the second year of the MCAA to present project information or disseminate project results. Additional information about the FY21 Melanoma Academy can be found on the MRP website.
Deadlines:
• Required Pre-Application Deadline: Sep. 14, 2022
• Application Submission Deadline: Oct. 5, 2022
To be considered for funding, applications for the FY22 MRP Mid-Career Accelerator Award (MCAA) must address at least one of the following FY22 MRP Focus Areas.
To be named as the PI on the application, the investigator must:
An investigator may be named on only one MCAA application as a PI.
The anticipated direct costs budgeted for the entire period of performance for an FY22 MRP MCAA will not exceed $725,000. Refer to Section II.D.5, Funding Restrictions, for detailed funding information.
